Recent advances in nonalcoholic fatty liver disease metabolomics

Hwi-Young KIM.
Clinical and Molecular Hepatology ; : 553-559, 2021.
Artículo en Inglés | WPRIM | ID: wpr-897692

Documentos relacionados

  1. Recent advances in nonalcoholic fatty liver disease metabolomics.
  2. Serum markers in diagnostics of steatohepatitis.
  3. Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.
  4. Recent advances in nonalcoholic fatty liver disease metabolomics
  5. Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
  6. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD.
  7. [Clinical significance of the measurement of serum cytokeratin-18 in patients with non-alcoholic steatohepatitis].
  8. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
  9. The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD.
  10. Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations.